Safety and Efficacy of Cisplatin Based Transarterial Chemo-Embolization in Combination with Gemcitabine and Cisplatin for Patients with Unresectable Cholangiocellular Carcinoma
Not Applicable
- Conditions
- Cholangiocellular Carcinoma
- Registration Number
- JPRN-UMIN000004776
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of malignant tumor 2) Severe cardiac disease 3) Active infection 4) History of HIV infection 5) Renal dialysis 6) Intracranial tumor 7) Clinically uncontrolled ascites or pleural effusion 8) Clinically severe gastrointestinal bleeding within 4 weeks of the start of treatment 9) Prior history of chemotherapy with gemcitabine and cisplatin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Overall Survival (OS) Progression Free Survival (PFS) 1-year Survival Rate 6 months Progression Free Survival Response Rate (RR)